Lifecore Biomedical Stock

Lifecore Biomedical ROE

The Return on Equity (ROE) of Lifecore Biomedical (LFCR) as of Aug 17, 2026 is 216.80 %. In the previous year, Return on Equity (ROE) was -2,897.98 % — a change of -107.48% (higher).

ROE

216.80 %

YoY

-107.48%

Last updated:

In 2026, Lifecore Biomedical's return on equity (ROE) was 216.80 %, a -107.48% increase from the -2,897.98 % ROE in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Lifecore Biomedical Stock analysis

What does Lifecore Biomedical do? Landec Corp is a US-American company specialized in the development, manufacturing, and marketing of innovative products in the Agribusiness and Biotechnology sectors. It was founded in 1986 as a spin-off from the engineering faculty of Stanford University. The company follows a unique business model based on the integration of advanced technologies and biological processes. This aims to achieve sustainable agriculture that is both mindful of natural resources and achieves high yields. One of Landec's main divisions is the Fresh-Cut Products segment, where the company produces a variety of high-quality salads, vegetable, and fruit snacks that are distributed under the brand Eat Smart®. These products are known for their freshness, taste, and healthy nutritional values, and have gained high recognition in the USA. Another important business division of Landec is the Apio Packaging segment, specialized in the manufacturing and marketing of innovative packaging solutions for fresh fruits and vegetables. The packaging, distributed under the brand BreatheWay®, is equipped with a unique technology that regulates gas exchange within the package and extends the shelf life of the contents. In addition to these core segments, Landec is also active in the field of Biotechnology. Here, the company develops innovative products and technologies for use in human healthcare as well as the agricultural industry. An example of this is Apio's recently introduced whole plant juice called GreenWise™. Landec Corp is known for its innovation capabilities and its ability to develop new products and technologies. Throughout its history, the company has acquired a number of patents and awards and constantly strives to improve and advance its products. Overall, Landec Corp is a company that focuses on sustainability, innovation, and quality. With its unique business model and wide range of products and services, the company is well-positioned to continue growing and expanding its leadership position in the agriculture and biotechnology industry. Lifecore Biomedical is one of the most popular companies on Eulerpool.

ROE Details

Decoding Lifecore Biomedical's Return on Equity (ROE)

Lifecore Biomedical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Lifecore Biomedical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Lifecore Biomedical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Lifecore Biomedical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Lifecore Biomedical stock

Return on Equity (ROE) of Lifecore Biomedical is 216.80 % in 2026.

Return on Equity (ROE) of Lifecore Biomedical changed from -2,897.98 % to 216.80 %, representing a -107.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Lifecore Biomedical since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Lifecore Biomedical with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Lifecore Biomedical

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Lifecore Biomedical